ALNYLAM PHARMACEUTICALS, INC.

Pharmaceutical Preparations | SIC: 2834
Phone: (617) 551-8200
CIK: 0001178670
EIN: 770602661
State Location: MA
Tickers:
  • Nasdaq:ALNY

Form: 10-K

Filing Date: 12 Feb 2026
Report Date: 31 Dec 2025
Accepted: 12 Feb 2026 06:12 a.m.
Accession Number: 0001628280-26-007497
Act: 34
File Number: 001-36407
Film Number: 26623520

Documents

Primary Document: 10-K
Accepted: 12 Feb 2026 06:12 a.m.